How do you utilize lenalidomide maintenance in non-transplant eligible myeloma?

Topics: Hematologic Malignancies • Medical Oncology • Myeloma • Hematology

Does the choice of initial induction regimen affect your decision for when to employ lenalidomide maintenance?

Are there situations where you would consider stopping therapy for a patient in a VGPR or better? Does MRD testing have a role in this decision-making?

Answer from: Medical Oncologist at Academic Institution

Maintenance is a standard of care management for both transplant eligible and transplant ineligible, regardless of type of induction regimen. Studies have shown benefit for both groups. Time to progression (PFS) almost twice as long for both groups with maintenance compared to no maintenan...

Comments

Medical Oncologist at Stephen B. Strum, MD PC
I am not an expert on multiple myeloma (MM) but am...

Related Questions